Presentation slides and video from the 2020-2021 Advances in Cancer Immunotherapy™ Series - Tucson, AZ held virtually on October 31, 2020 are available here. Program Organizers Emmanuel Katsanis, MD – University of Arizona Ali McBride, PharmD, MS, BCPS, BCOP, FAzPA – University...
18 attachments
Nasopharyngeal carcinoma (NPC) is primarily caused by the Epstein-Barr virus (EBV) infection in NPC endemic areas. EBNA1 is an EBV-encoded nuclear antigen, which plays a critical role in the maintenance and replication of EBV genome. However, the mechanisms of EBNA1-promoted NPC immune escape...
Presentation slides and video from the 2020-2021 Advances in Cancer Immunotherapy™ Series - Seattle, WA held virtually on October 31, 2020 are available here. Program Organizers Shailender Bhatia, MD – University of Washington Petros Grivas, MD, PhD – University of Washington ...
16 attachments
Presentation slides and video from the 2020-2021 Advances in Cancer Immunotherapy™ Series - New Haven, CT held virtually on October 28, 2020 are available here. Program Organizers Marianne Davies, DNP, AOCNP – Yale School of Nursing Roy S. Herbst, MD, PhD – Yale Cancer Center ...
20 attachments
Presentation slides and video from the 2020-2021 Advances in Cancer Immunotherapy ™ Series - Pittsburgh, PA held virtually on October 24, 2020 are available here. Program Organizers Tullia C. Bruno, PhD – University of Pittsburgh Robert L. Ferris, MD, PhD – UPMC Hillman Cancer...
Immunotherapy has emerged as a promising treatment modality for head and neck squamous cell carcinoma (HNSCC). Pembrolizumab, an anti-programmed death 1 antibody, is an immunotherapy agent currently approved for metastatic HNSCC and curative intent clinical trials. Although clinical responses to...
The authors purpose in this study was to determine safety and efficacy of single cycle induction treatment with cisplatin/docetaxel and durvalumab/tremelimumab in stage III-IVB head and neck cancer. They concluded that single cycle induction treatment with cisplatin/docetaxel and durvalumab...
Presentation slides and video from the 2020-2021 Advances in Cancer ImmunotherapyTM Series - Madison, WI held virtually on September 24, 2020 are available here. Program Organizers Christian M. Capitini, MD – University of Wisconsin Carbone Cancer Center Carissa Dolens, DNP, AGPCNP...
Presentation slides and video from the 2020-2021 Advances in Cancer Immunotherapy TM Series - Salt Lake City, UT held virtually on February 18, 2021 are available here. Program Organizers Sumati Gupta, MD – Huntsman Cancer Institute Megan Mullalley, PharmD, BCOP, BCPS – Intermountain...
23 attachments
Presentation slides and video from the 2020-2021 Advances in Cancer Immunotherapy™ Series - Boston, MA held virtually on September 10, 2020 are available here. Program Organizers Elizabeth Buchbinder, MD – Dana-Farber Cancer Institute David F. McDermott, MD – Beth Israel Deaconess...
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us